News

Darwin Biosciences, CU Boulder spinoff and creator of the Sick Stick, have developed a rapid, portable, saliva-based COVID-19 test able to return results in 45 minutes. Such a test might eventually be deployable in community settings like schools and factories, and efforts are underway to conduct further validation tests and seek regulatory approval.

New Iridium, a company developing commercialized photocatalysis technologies to accelerate drug development and manufacturing, has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $256,000 to conduct research and development work on facilitating timely availability of Remdesivir, a potential life-saving drug in the global fight against COVID-19.

This award will enable further research into the unique electromechanical failure mechanism in HASEL actuators, a new class of smart, soft, high-speed robotic hardware.

The University of Colorado jumped from No. 53 to No. 20 in a recent global ranking of the top 100 universities granted U.S. utility patents. All four campuses contributed to CU’s total 100+ patents, with CU Boulder contributing 60.

Researchers at CU Boulder, led by Professor Mike McGehee in the College of Engineering and Applied Science, have developed an improved method for controlling smart tinting on windows that could make them cheaper, more effective and more durable than current options on the market.

CU Boulder biomedical engineer Jacob Segil is working to bring back a sense of touch for amputees, including veterans of the wars in Iraq and Afghanistan.

CU Boulder researchers and the CU spinoff VitriVax Inc., are focused on finding a way to get vaccines to 7.8 billion people. The research team is able to do so with funding, licensing and startup support from Venture Partners at CU Boulder, the university’s commercialization arm.

Venture Partners at CU Boulder is identifying new innovations that address problems related to the COVID-19 pandemic.

Researchers are fast-tracking a new CU-born technology, SickStick, in hopes of not only helping to curb the current pandemic but also radically change the way we track disease in the future.

The next businesses to make a splash will come out of Colorado’s research institutions, including CU Boulder. Venture Partners' Managing Director Bryn Rees is featured in the article.